Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of β-lactam/β-lactamase inhibitor combinations

This publication has 23 references indexed in Scilit:

• Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns
  Journal of Antimicrobial Chemotherapy, 2000
• Clinical relevance of Proteus mirabilis in hospital patients: a two year survey
  Journal of Antimicrobial Chemotherapy, 2000
• Evaluation of clonal relatedness of extended-spectrum β-lactamase-producing Proteus mirabilis isolates by quantitative antibiogram and RAPD typing
  Clinical Microbiology & Infection, 1997
• Tazobactam-Piperacillin Compared with Sulbactam-Ampicillin, Clavulanic Acid-Ticarcillin, Sulbactam-Cefoperazone, and Piperacillin for Activity against Beta-Lactamase-Producing Bacteria Isolated from Patients with Complicated Urinary Tract Infections
  Journal of Chemotherapy, 1997
• National survey of the in vitro spectrum of piperacillin-tazobactam tested against more than 40,000 aerobic clinical isolates from 236 medical centers
  Diagnostic Microbiology and Infectious Disease, 1995
• Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers a reevaluation after five years
  Diagnostic Microbiology and Infectious Disease, 1995
• -Lactam Resistance in Gram-Negative Bacteria: Global Trends and Clinical Impact
  Clinical Infectious Diseases, 1992
• Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France
  Antimicrobial Agents and Chemotherapy, 1992
• Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens
  Infection, 1983
• Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third generation cephalosporins
  Journal of Antimicrobial Chemotherapy, 1983